Scribe Therapeutics SCTX Ratios (2025-2026)

NASDAQ SCTX
$16.86 -0.50 (-2.88%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Scribe Therapeutics Quarterly Ratios

Periods 5 quarters
Latest Jun 2026

Scribe Therapeutics reported a net margin of -337.70% for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Mar 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin -21.84%-216.72%-766.64%-326.64%
EBIT Margin -32.45%-237.38%-556.52%-489.83%
EBITDA Margin -28.07%-223.09%-528.03%-458.55%
Operating Margin -32.45%-237.38%-556.52%-489.83%
Net Margin -20.00%-202.18%-776.85%-337.70%
FCF Margin -76.67%-164.39%-337.57%-280.55%
Efficiency
Assets AverageAssets Avg. 71.71M61.57M
Equity AverageEquity Avg. -127.26M-133.28M-140.65M-151.08M-161.79M
Invested CapitalInvested Cap. -108.08M-118.19M-127.05M
Asset Utilization RatioAsset Util. 0.43
Leverage & Solvency
Interest Coverage RatioInterest Cover -9.29-19.44-20.78-34.04
Debt Ratio 0.450.620.65
Times Interest Earned -9.29-19.44-20.78-34.04
Return Ratios
Return on Sales [ROS]ROS -32.45%-237.38%-556.52%-489.83%
Return on Assets [ROA]ROA -60.63%

Scribe Therapeutics Ratios API

Pull Scribe Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SCTX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY